[HTML][HTML] Alternative approaches to target Myc for cancer treatment

C Wang, J Zhang, J Yin, Y Gan, S Xu, Y Gu… - Signal transduction and …, 2021 - nature.com
The Myc proto-oncogene family consists of three members, C-MYC, MYCN, and MYCL,
which encodes the transcription factor c-Myc (hereafter Myc), N-Myc, and L-Myc …

[HTML][HTML] miRNAs reshape immunity and inflammatory responses in bacterial infection

X Zhou, X Li, M Wu - Signal transduction and targeted therapy, 2018 - nature.com
Pathogenic bacteria cause various infections worldwide, especially in immunocompromised
and other susceptible individuals, and are also associated with high infant mortality rates in …

[HTML][HTML] Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors

S Anthiya, SC Öztürk, H Yanik, E Tavukcuoglu… - Journal of Controlled …, 2023 - Elsevier
K-RAS is a highly relevant oncogene that is mutated in approximately 90% of pancreatic
cancers and 20–25% of lung adenocarcinomas. The aim of this work was to develop a new …

[HTML][HTML] Selective and noncovalent targeting of RAS mutants for inhibition and degradation

KW Teng, ST Tsai, T Hattori, C Fedele, A Koide… - Nature …, 2021 - nature.com
Activating mutants of RAS are commonly found in human cancers, but to date selective
targeting of RAS in the clinic has been limited to KRAS (G12C) through covalent inhibitors …

[HTML][HTML] Crosstalk between miRNAs and DNA Methylation in Cancer

M Saviana, P Le, L Micalo, D Del Valle-Morales… - Genes, 2023 - mdpi.com
miRNAs are some of the most well-characterized regulators of gene expression. Integral to
several physiological processes, their aberrant expression often drives the pathogenesis of …

[HTML][HTML] Mammalian antiviral systems directed by small RNA

T Takahashi, SM Heaton, NF Parrish - PLoS pathogens, 2021 - journals.plos.org
There are strong incentives for human populations to develop antiviral systems. Similarly,
genomes that encode antiviral systems have had strong selective advantages. Protein …

[HTML][HTML] Non-coding RNAs in cancer diagnosis and therapy: focus on lung cancer

P Le, G Romano, P Nana-Sinkam, M Acunzo - Cancers, 2021 - mdpi.com
Simple Summary Researchers have spent nearly two decades unraveling the roles of non-
coding RNAs in cancer biology. In recent years, deep transcriptomic profiling of tissue and …

[HTML][HTML] Actionability classification of variants of unknown significance correlates with functional effect

A Johnson, PKS Ng, M Kahle, J Castillo… - npj Precision …, 2023 - nature.com
Genomically-informed therapy requires consideration of the functional impact of genomic
alterations on protein expression and/or function. However, a substantial number of variants …

MicroRNAs and cancer: a long story for short RNAs

A Drusco, CM Croce - Advances in cancer research, 2017 - Elsevier
More than six decades ago Watson and Crick published the chemical structure of DNA. This
discovery revolutionized our approach to medical science and opened new perspectives for …

[HTML][HTML] Overexpression of human BAG3P209L in mice causes restrictive cardiomyopathy

K Kimura, A Ooms, K Graf-Riesen… - Nature …, 2021 - nature.com
An amino acid exchange (P209L) in the HSPB8 binding site of the human co-chaperone
BAG3 gives rise to severe childhood cardiomyopathy. To phenocopy the disease in mice …